GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tascom Co Ltd (XKRX:336040) » Definitions » Notes Receivable

Tascom Co (XKRX:336040) Notes Receivable : ₩0.00 Mil (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Tascom Co Notes Receivable?

Tascom Co's Notes Receivable for the quarter that ended in . 20 was ₩0.00 Mil.


Tascom Co Notes Receivable Historical Data

The historical data trend for Tascom Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tascom Co Notes Receivable Chart

Tascom Co Annual Data
Trend
Notes Receivable

Tascom Co Semi-Annual Data
Notes Receivable

Tascom Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Tascom Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of Tascom Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tascom Co Business Description

Traded in Other Exchanges
N/A
Address
43 BanPo-daero 28-gil, 5th Floor, i-SENS Building, SeoCho-gu, Seoul, KOR
Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.

Tascom Co Headlines

No Headlines